Compounding Pharmacy · Miami, FL · 503A
The Pharmacy Hub Review
The Pharmacy Hub is a 503A compounding pharmacy at 15600 NW 15th Ave Suite C, Miami, FL 33169, named by CLYR Health as its dispensing partner for compounded semaglutide and tirzepatide.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Telehealth Providers Sourcing From This Pharmacy
These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through The Pharmacy Hub. Sourcing arrangements can change over time.
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
CLYR Health
Best for: Flat-rate compounded GLP-1 with pricing that does not increase as your dose goes up
Editorial score · methodology
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed
The Pharmacy Hub has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Low confidence · Last verified 2026-07-16 via manual · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of July 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.